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AbstRACt
Multiple pregnancy is a known complication of in‑vitro fertilization and embryo transfer (IVF-ET). It is usually associated 
with serious perinatal morbidity and/or mortality as well as significant maternal morbidity and efforts to reduce these has led 
to the concept of elective single embryo transfer (ESET) in developed countries, this concept has not been entrenched in 
the practice in Nigeria. We report a case of quadruplet pregnancy following the transfer of three embryos following IVF and 
reviewed the relevant literature.
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Introduction
Higher order multiple pregnancies (HOMP) are a serious 
complication of in‑vitro fertilisation (IVF). In developed 
countries, efforts are being made to reduce the number of 
embryo transferred following the treatment, but in Nigeria 
there are no clear guidelines on the number of embryo that 
can be transferred resulting in a high incidence of HOMP in 
IVF treatments in Nigeria. We report a case of quadruplet 
pregnancy following the transfer of 3 embryos.
Case Report
Mrs. A.I was a 48-year-old married woman who was 
cohabiting with her husband for the past 17 years without 
conception despite unprotected sexual intercourse about 
three times per week which was said to be satisfactory. 
Husband had no children outside the marriage and had no 
previous pregnancy.
She attained menarche at 18 years, menstruated for 5 days 
in a regular 28-day menstrual cycle until March 2013. 
She had no menorrhagia, dysmenorrhea, dyspareunia, or 
postcoital bleeding. There was no intermenstrual bleeding, 
or postmenopausal bleeding. She was aware of modern use 
of contraceptives and used none. There was no previous 
pap smear. There were no previous abortions or treatments 
for sexually transmitted infections or pelvic inflammatory 
disease.
She had no anterior neck swelling, heat or cold intolerance, 
and palpitations or fine tremors. There were no recurrent 
frontal headaches, changes in sense of smell, or abnormal 
milky nipple discharges. There was no increasing acne, 
deepening of voice, or abnormal male hair pattern.
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She had two previous myomectomies in 1999 and 2010; 
had at least one unit of whole blood transfused on both 
occasions. She was not a known hypertensive, diabetic, 
peptic ulcer disease, or asthmatic patient. She previously 
used clomiphene citrate and vitamin E routinely and there 
were no known drug allergies.
She was married to a 52-year-old trader in a monogamous 
family setting. She did not consume alcohol nor smoked 
cigarettes.
Her husband was able to initiate and sustain an erection 
and also ejaculate. He did not wear tight underwear and 
there was no previous abdominal or groin surgery. He was 
not a known hypertensive or diabetic patient. He consumed 
alcohol occasionally, but smoked for a period of 5 years 
about 20 years ago.
Examination revealed a middle-aged woman, conscious and 
alert, not pale, anicteric, acyanosed, not dehydrated with 
no pedal edema.
Anthropometric measurements: Height = 1.58 m; 
Weight = 65 kg, and BMI = 26.0 km/m2 (overweight)
Examination of the head, neck, and respiratory system did 
not reveal any abnormalities.
Her pulse rate was 110 bpm, regular with thickened arterial wall, 
and locomotor brachialis. Blood pressure was 180/110 mmHg; 
Apex beat was in fifth left intercostal space lateral to 
mid-clavicular line. Heart sounds S4, S1, and S2 only, no murmur.
The abdomen was full, soft moved with respiration. There 
were two previous midline infraumbilical to suprapubic scar. 
There was no area of tenderness, no ascites demonstrable, 
and bowel sounds were normoactive.
Vaginal examination revealed a normal female external 
genitalia, cervix was healthy looking deficient in the posterior 
lip with a mild stenosis of the internal os which overcomes 
with resistance. Uterus was anteverted or slightly deviated 
to the right and depth of 7 cm.
Based on the history and examination findings, an assessment 
of primary infertility in a postmenopausal woman with 
hypertension was made.
She was counselled and scheduled for in vitro fertilization, 
egg donation, and embryo transfer. She was immediately 
commenced on antihypertensives and when the blood 
pressure normalized she was commenced on hormone 
replacement therapy.
The couple had some investigations done and the results are 
shown on Tables 1 and 2.
She had hormonal profile which revealed follicle 
stimulating hormone (FSH) = 103.20 mIU/ml (elevated); 
luteinizing hormone (LH) = 65.42 mIU/ml (elevated); 
prolactin = 341.80 uIU/ml, and estradiol = 5.0pg/ml; a 
postmenopausal state.
She subsequently had in‑vitro fertilization and Day 5 
blastocyst transfer on 7 August 2014. Three expanded 
blastocysts were transferred into the endometrial cavity with 
the aid of a Labotect catheter under ultrasound guidance. 
Embryo transfer was smooth.
She had luteal phase support with IM progesterone in oil 
100 mg OD, PV cyclogest pessaries 400 mg BD, PO progynova 
6 mg OD, and PO folic acid 5 mg OD.
14th day post transfer, serum βHCG was positive, and 
hormonal support was continued until 12 weeks gestation.
Pelvic ultrasound done at estimated gestation age of 10 weeks 
showed three gestational sacs with four identifiable fetal 
poles and crown-rump lengths approximately 10W + 2D. 
She was then schedule for a prophylactic cervical cerclage 
after 12 weeks gestation which she had.
She booked pregnancy at gestational age of 14W + 5D, 
she received two doses of tetanus toxoid and intermittent 







Blood Group O Negative B Positive
Genotype AA AA
RBS 6.2 mmol/L 6.4 mmol/L




Motility Active – 63%; Sluggish – 12%; Non-motile – 25%
Morphology Normal – 40%; Abnormal – 60%
RBC 1-2/hpf
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preventive therapy for malaria at 22W + 5D and 26W + 5D 
respectively. She was admitted for bed rest in the hospital 
at 26 weeks gestation and was commenced on prophylactic 
steroid IM dexamethasone 12 mg BD weekly.
On 21 February 2015, at gestational age of 30W + 2D she 
started having preterm labor and was scheduled for an 
emergency cesarean section and delivered a set of female 
quadruplets; T1 weighed 1.2 kg APGAR 91105; T2 weighed 
1.25 kg APGAR 91 105; T3 weighed 1.4 kg APGAR 101 105; 
T4 weighed 1.2 kg APGAR 91 105. Babies were immediately 
admitted in the neonatal intensive care unit, placenta was 
delivered by controlled cord traction, and estimated blood 
loss was 800 ml. Babies were admitted on account of 
prematurity and low birthweight. Mother was discharged 
on sixth postoperative day, postoperative condition was 
uneventful with PCV = 34%. Babies were admitted for a 
period of 4 weeks after which they were discharged home in 
good condition. Weight at discharge was 1.7 kg, 1.8 kg, 2.4 
kg, and 1.7 kg, respectively. The picture of the babies after 
discharge are shown in Figure 1.
Six weeks post-delivery both mother and babies were seen 
and in satisfactory conditions. Babies were commenced on 
immunization according to the National Programme for 
Immunization.
Discussion
The high frequency of multiple births is the main factor 
which leads to adverse outcome in IVF/intracytoplasmic 
sperm injection (ICSI) treatments. Transfer of two embryos 
does not diminish the chance of a birth when compare 
with three embryo transfer, if more than four embryos are 
available for transfer.[1] However, in many countries more than 
two embryos are still generally transferred especially in IVF 
centers in Nigeria.
This woman had three embryo transferred because of her 
age coupled with two previous myomectomies which we 
thought will diminish the endometrial receptivity as a result 
of scarring, but she ended up with a quadruplet pregnancy, 
hence there is the need to have a limit to the number of 
embryo transferred in IVF practice in Nigeria.
In the USA, the average number of embryos transferred is 
four and the multiple pregnancy rate (PR) is ~40% in IVF/ICSI 
treatments.[2]
It has been estimated that one embryo is more cost effective 
than two embryo transfer when all the cost associated with 
multiple gestations are taken into account.[3]
Multiple pregnancies cause several well-documented 
pathologies, extensively reviewed everywhere.[4] They 
comprise a maternal risk for obstetric complications, 
hypertension, preeclampsia, preterm labor, anemia, and 
an increased cesarean section rate; fetal or neonatal risk 
for increased mortality, lower gestational age, lower 
birth weight, respiratory distress syndrome, necrotizing 
enterocolitis, sepsis, intracranial hemorrhage, congenital 
malformations, the twin-twin transfusion syndrome, cerebral 
palsy, and long-term neurological complications; and family 
complications of psychological, social, and financial nature.[5]
Following birth, multiples suffer from increased rates of learning 
difficulties and perceptual disabilities.[6] Growth-restricted 
twins are at increased risk of poor postnatal growth and speech 
and behavioral problems compared with their appropriately 
grown siblings.[7] Further, the differences in locomotive, 
hearing, speech, and practical reasoning scores increase with 
the degree of birth weight discordance.[8] Similarly, increased 
morbidity and mortality has been reported in IVF twins 
compared with IVF singletons.[9] Compared with IVF singletons, 
IVF twins have a 10-fold increased risk of preterm (<37 weeks) 
delivery, a 7-fold increased risk of delivery before 32 weeks’ 
gestation, and a 12-fold and 5-fold increased risk of birth 
weight <2500 g and <1500 g, respectively. The risk of stillbirth 
is doubled.[9] However, incidence of neurological sequelae 
appears to be similar.[10]
Mrs. A.I has a set of quadruplets following IVF with transfer of 
three embryos and luckily the babies did not suffer any of the 
Figure 1: The Quadruplets after discharge from NICU
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aforementioned complications. Many IVF patients in Nigeria 
are not that lucky and many of the higher order multiple 
pregnancies (HOMP) end up in miscarriages or extreme 
premature births with neonatal complications.
Transferring just one embryo even of ideal morphology in an 
ideal recipient was a taboo, because it was feared that the PR 
would drop below that of our nearest neighbor or below the 
layman’s and the media’s expectations.[5] Even if the society is 
willing to pay for the extra costs incurred, money can never 
restore health irreparably lost and even if it could, society should 
ask whether this is really needed, provided chances to conceive 
after IVF/ICSI are not substantially decreased without running 
those risks. There is a strong philosophical argumentation 
putting the responsibility for our children’s good health at the 
start of their life on all those involved in IVF/ICSI (patients, health 
care providers, health insurers, and politicians).[5]
There is an urgent need for practitioners in the fertility health 
care units in Nigeria to come up with guidelines on the 
number of embryo to transfer so as to reduce the incidence 
of HOMP in Nigeria.
In developed countries, the practice of elective single-embryo 
transfer has been advocated and studies have shown that this 
does not reduce PR especially in younger women.[11]
Conclusion
In conclusion there is a need to reduce the number of higher 
order multiple birth in IVF practice in Nigeria and the way to 
achieve this is through the production of evidence based practice 
guidelines by the stakeholder in the professional association.
Adoption of the ESET will drastically reduce the incidence 
of multiple pregnancy, but may not eliminate it completely 
due to monozygotic twining, this will result in an improved 
quality of life for babies born through this technology and 
hence the parental satisfaction.
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